{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:23:38Z","timestamp":1787743418396,"version":"build-2784847793"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To describe the rate and surgical outcomes of sentinel lymph node (SLN) biopsy in patients with endometrial intraepithelial neoplasia (EIN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a cohort study that used the prospective American College of Surgeons National Surgical Quality Improvement Program database. Women with EIN on postoperative pathology who underwent minimally invasive hysterectomy from 2012 to 2020 were included. The cohort was dichotomized based on the performance of SLN biopsy. Patients' characteristics, perioperative morbidity, and mortality were compared between patients who underwent SLN biopsy and those who did not. Postoperative complications were defined using the Clavien-Dindo classification system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Overall, 4,447 patients were included; of those, 586 (13.2%) underwent SLN biopsy. The proportion of SLN biopsy has increased steadily from 0.6% in 2012 to 26.1% in 2020 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001), with a rate of 16% increase per year. In a multivariable regression that included age, body mass index (BMI), and year of surgery, a more recent year of surgery was independently associated with an increased adjusted odds ratio of undergoing SLN biopsy (1.51, 95% CI, 1.43\u20131.59). The mean total operative time was longer in the SLN biopsy group (139.50\u00b150.34 minutes vs 131.64\u00b155.95 minutes,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.001). The rate of any complication was 5.9% compared with 6.7%, the rate of major complications was 2.3% compared with 2.4%, and the rate of minor complications was 4.1% compared with 4.9% for no SLN biopsy and SLN biopsy, respectively. In a single complications analysis, the rate of venous thromboembolism was higher in the SLN biopsy group (four [0.7%] vs four [0.1%],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.013). In a multivariable regression analysis adjusted for age, BMI, American Society of Anesthesiologists classification, uterus weight, and preoperative hematocrit, the performance of SLN biopsy was not associated with any complications, major complications, or minor complications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The performance of SLN biopsy in EIN is increasing. Sentinel lymph node biopsy for EIN is associated with an increased risk of venous thromboembolism and a negligible increased surgical time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005637","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T17:02:16Z","timestamp":1717693336000},"page":"275-282","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Utilization and Surgical Outcomes of Sentinel Lymph Node Biopsy for Endometrial Intraepithelial Neoplasia"],"prefix":"10.1097","volume":"144","author":[{"given":"Gabriel","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yechiel Z.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacey M.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raanan","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"R1-20260826","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/1471-0528.14385","article-title":"Premenopausal abnormal uterine bleeding and risk of endometrial cancer","volume":"124","author":"Pennant","year":"2017","journal-title":"BJOG"},{"key":"R2-20260826","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1525-1438.2007.00925.x","article-title":"The relation between age, time since menopause, and endometrial cancer in women with postmenopausal bleeding","volume":"17","author":"van Doorn","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"R3-20260826","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R4-20260826","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00019606-200212000-00003","article-title":"Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia","volume":"11","author":"Sun","year":"2002","journal-title":"Diagn Mol Pathol"},{"key":"R5-20260826","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"R6-20260826","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/modpathol.3880051","article-title":"Theories of endometrial carcinogenesis: a multidisciplinary approach","volume":"13","author":"Sherman","year":"2000","journal-title":"Mod Pathol"},{"key":"R7-20260826","doi-asserted-by":"crossref","first-page":"e0232231","DOI":"10.1371\/journal.pone.0232231","article-title":"Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: a systematic review and meta-analysis","volume":"15","author":"Doherty","year":"2020","journal-title":"PLoS One"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2022.10.023","article-title":"Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia?","volume":"168","author":"Matanes","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R9-20260826","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ygyno.2017.12.026","article-title":"The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia","volume":"148","author":"Touhami","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R10-20260826","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000525850","article-title":"Nodal assessment in endometrial atypical hyperplasia","volume":"87","author":"Capozzi","year":"2022","journal-title":"Gynecol Obstet Invest"},{"key":"R11-20260826","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/AOG.0000000000002100","article-title":"Patterns of specialty-based referral and perioperative outcomes for women with endometrial cancer undergoing hysterectomy","volume":"130","author":"Wright","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R12-20260826","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/01.AOG.0000465189.50026.20","article-title":"Endometrial intraepithelial neoplasia. Committee Opinion No. 631. American College of Obstetricians and Gynecologists","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R13-20260826","doi-asserted-by":"crossref","first-page":"609.e1","DOI":"10.1016\/j.ajog.2022.05.055","article-title":"Hysterectomy with a general gynecologist vs gynecologic-oncologist in the setting of endometrial intraepithelial neoplasia: a cost-effectiveness analysis","volume":"227","author":"Chaiken","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20260826","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/AOG.0000000000004352","article-title":"Uptake and outcomes of sentinel lymph node mapping in women with atypical endometrial hyperplasia","volume":"137","author":"Dioun","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R15-20260826","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/AOG.0000000000004733","article-title":"Utilization and outcomes of sentinel lymph node biopsy for early endometrial cancer","volume":"139","author":"Matsuo","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"8","key":"R16-20260826","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1007\/s00464-023-10081-2","article-title":"Lymph node evaluation for endometrial hyperplasia: a nationwide analysis of minimally invasive hysterectomy in the ambulatory setting","volume":"37","author":"Matsuo","year":"2023","journal-title":"Surg Endosc"},{"key":"R17-20260826","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jamcollsurg.2012.11.013","article-title":"Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program","volume":"216","author":"Sellers","year":"2013","journal-title":"J Am Coll Surg"},{"key":"R19-20260826","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"R20-20260826","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/AOG.0000000000005297","article-title":"Management of endometrial intraepithelial neoplasia or atypical endometrial hyperplasia. ACOG Clinical Consensus No. 5. American College of Obstetricians and Gynecologists","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R21-20260826","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ajog.2018.12.010","article-title":"Does surgical treatment of atypical endometrial hyperplasia require referral to a gynecologic oncologist?","volume":"220","author":"Shalowitz","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20260826","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/AOG.0000000000005284","article-title":"Geographic disparities in potential accessibility to gynecologic oncologists in the United States from 2001 to 2020","volume":"142","author":"Desjardins","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R23-20260826","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ygyno.2021.07.004","article-title":"Lymph node assessment at the time of hysterectomy has limited clinical utility for patients with pre-cancerous endometrial lesions","volume":"162","author":"Sullivan","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R24-20260826","doi-asserted-by":"crossref","first-page":"108006","DOI":"10.1016\/j.ejso.2024.108006","article-title":"Machine learning for prediction of concurrent endometrial carcinoma in patients diagnosed with endometrial intraepithelial neoplasia","volume":"50","author":"Levin","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"R25-20260826","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.17763","article-title":"Time interval from biopsy of endometrial atypical hyperplasia to surgery and risk for concurrent endometrial carcinoma\u2014a retrospective study","author":"Levin","year":"2024","journal-title":"BJOG"},{"key":"R26-20260826","doi-asserted-by":"crossref","first-page":"60.e1","DOI":"10.1016\/j.ajog.2019.08.002","article-title":"Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia","volume":"222","author":"Vetter","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R27-20260826","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/1471-0528.17085","article-title":"Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancer","volume":"129","author":"Dioun","year":"2022","journal-title":"BJOG"},{"key":"R28-20260826","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1007\/s00464-023-10081-2","article-title":"Lymph node evaluation for endometrial hyperplasia: a nationwide analysis of minimally invasive hysterectomy in the ambulatory setting","volume":"37","author":"Matsuo","year":"2023","journal-title":"Surg Endosc"},{"key":"R29-20260826","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2018.09.020","article-title":"Hysterectomy with sentinel lymph node biopsy in the setting of pre-operative diagnosis of endometrial intraepithelial neoplasia: a cost-effectiveness analysis","volume":"151","author":"Lim","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R30-20260826","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.gore.2017.11.006","article-title":"Geographic disparities in the distribution of the U.S. Gynecologic Oncology Workforce: a Society of Gynecologic Oncology study","volume":"22","author":"Ricci","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"R31-20260826","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.juro.2014.08.091","article-title":"Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection","volume":"193","author":"Tyritzis","year":"2015","journal-title":"J Urol"},{"key":"R32-20260826","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ejso.2023.02.006","article-title":"Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: perioperative and long-term results from a propensity-score based study","volume":"49","author":"Bogani","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"R33-20260826","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2024.01.026","article-title":"Role of sentinel lymph node evaluation during hysterectomy for preoperative pathology diagnosis of endometrial intraepithelial neoplasia in a community hospital setting","volume":"184","author":"Leite","year":"2024","journal-title":"Gynecol Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:02:12Z","timestamp":1787742132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005637","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"2024-03-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}